Neutralization Potential of the Plasma of HIV-1 Infected Indian Patients in the Context of Anti-V3 Antibody Content and Antiretroviral Theraphy

Alok Kumar Choudhary; Raiees Andrabi; Somi Sankaran Prakash; Rajesh Kumar; Shubhasree Dutta Choudhury Choudhury; Naveet Wig; Ashutosh Biswas; Anjali Hazarika; Kalpana Luthra

doi:10.1007/s12275-012-1246-y

Articles

Page Path: HOME > J. Microbiol > Volume 50(1); 2012 > Article

Research Support, Non-U.S. Gov't
Neutralization Potential of the Plasma of HIV-1 Infected Indian Patients in the Context of Anti-V3 Antibody Content and Antiretroviral Theraphy: Alok Kumar Choudhary ¹, Raiees Andrabi ¹, Somi Sankaran Prakash ¹, Rajesh Kumar ¹, Shubhasree Dutta Choudhury Choudhury ¹, Naveet Wig ², Ashutosh Biswas ², Anjali Hazarika ³, Kalpana Luthra ¹; Journal of Microbiology 2012;50(1):149-154.
DOI: https://doi.org/10.1007/s12275-012-1246-y
Published online: February 27, 2012

¹Department of Biochemistry, CN Centre, All India Institute of Medical Sciences, 110029, New Delhi, India, ²Department of Medicine, CN Centre, All India Institute of Medical Sciences, 110029, New Delhi, India, ³Department of Blood Bank, CN Centre, All India Institute of Medical Sciences, 110029, New Delhi, India

Corresponding author: Kalpana Luthra , Tel: +91-11-26546431,

Received: 16 May 2011 • Accepted: 19 October 2011

prev next

233 Views
0 Download
7 Crossref
8 Scopus

Full Article

Download PDF

Abstract

We assessed the anti-V3 antibody content and viral neutralization potential of the plasma of 63 HIV-1-infected patients (antiretroviral naïve=39, treated=24) against four primary isolates (PIs) of clade C and a tier 1 clade B isolate SF162. Depletion and inhibition of anti-V3 antibodies in the plasma of five patients with high titers of anti-V3 antibodies led to modest change in the neutralization percentage against two PIs (range 0–21%). The plasma of antiretroviral-treated patients exhibited higher neutralization potential than that of the drug-naïve plasmas against the four PIs tested which was further evidenced by a follow-up study.

Keywords: HIV-1;India;neutralizing antibodies;anti-V3 antibodies;antiretroviral therapy

Figure & Data

References

Citations

Citations to this article as recorded by

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children
Sanjeev Kumar, Himanshu Batra, Swarandeep Singh, Himanshi Chawla, Ravinder Singh, Sanket Katpara, Abdul Wahid Hussain, Bimal Kumar Das, Rakesh Lodha, Sushil Kumar Kabra, Kalpana Luthra
Journal of General Virology .2020; 101(12): 1289. CrossRef
Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
Narayanaiah Cheedarla, K. Lucia Precilla, Hemalatha Babu, K. K. Vidya Vijayan, Manickam Ashokkumar, Padmapriyadarsini Chandrasekaran, Nandagopal Kailasam, Jagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Viswanath Buddolla, S. Kalyanaraman Vaniamba
Scientific Reports.2017;[Epub] CrossRef
Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India
Muzamil A. Makhdoomi, Lubina Khan, Sanjeev Kumar, Heena Aggarwal, Ravinder Singh, Rakesh Lodha, Mohit Singla, Bimal K. Das, Sushil K. Kabra, Kalpana Luthra
Journal of General Virology.2017; 98(7): 1879. CrossRef
CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children
Sanjeev Kumar, Rajesh Kumar, Lubina Khan, Muzamil Ashraf Makhdoomi, Ramachandran Thiruvengadam, Madhav Mohata, Mudit Agarwal, Rakesh Lodha, Sushil Kumar Kabra, Subrata Sinha, Kalpana Luthra
Frontiers in Immunology.2017;[Epub] CrossRef
Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library
Lubina Khan, Rajesh Kumar, Ramachandran Thiruvengadam, Hilal Ahmad Parray, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, Heena Aggarwal, Madhav Mohata, Abdul Wahid Hussain, Raksha Das, Raghavan Varadarajan, Jayanta Bhattacharya, Madhu Vajpayee, K. G. Murugavel
Scientific Reports.2017;[Epub] CrossRef
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy
Linlin Gu, Valentina Krendelchtchikova, Alexandre Krendelchtchikov, Robert A Oster, Kohtaro Fujihashi, Qiana L Matthews
Virology Journal.2014;[Epub] CrossRef
Highly Efficient Neutralization by Plasma Antibodies from Human Immunodeficiency Virus Type-1 Infected Individuals on Antiretroviral Drug Therapy
Raiees Andrabi, M. A. Makhdoomi, Rajesh Kumar, Manju Bala, Hilal Parray, Arjun Gupta, Ankita Kotnala, Velpandian Thirumurthy, Kalpana Luthra
Journal of Clinical Immunology.2014; 34(4): 504. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Neutralization Potential of the Plasma of HIV-1 Infected Indian Patients in the Context of Anti-V3 Antibody Content and Antiretroviral Theraphy

J. Microbiol. 2012;50(1):149-154. Published online February 27, 2012

DOI: https://doi.org/10.1007/s12275-012-1246-y

Related articles